RESULTS: A total of 2,055 patients were identified. The rate of EDPP prescriptions for patients discharged after RC increased significantly over the study period, from 9% of cases in 2012 to 26% of cases in 2017 (p<0.001 CONCLUSIONS: EDPP following RC has increased over time, but is still provided for only a minority of cases. Further efforts are warranted to study the potential benefits and risks of EDPP as utilization increases.
INTRODUCTION AND OBJECTIVES:
Guidelines from the EAU and other organizations recommend prolonged anticoagulation after radical cystectomy for the prevention of venous thromboembolic events (VTE). Low molecular weight heparin is generally the anticoagulant of choice, but it is both expensive and a burden for patients to administer. The benefit of extended duration anticoagulation in guideline statements is estimated using assumptions of risk reduction based on RCTs in other areas (e.g. orthopedics), but do not include randomized studies of cystectomies with no prolonged anticoagulation. In order to provide an estimate of real world risk with and without prolonged prophylaxis, we performed a systematic review of cystectomy studies to assess reported risks of VTE in the published literature.
METHODS: PubMed and Medline were queried for all studies pertaining to "radical cystectomy" to capture all series of cystectomies. Studies in English reporting on patients operated on after 1990 with data on post-discharge prophylaxis, deep venous thromboembolism (DVT) and pulmonary embolism (PE) were included. Data on inhospital and post-discharge prophylaxis, rates of DVT, PE and bleeding complications were collected. These data were pooled to estimate rates of these events with and without prolonged anticoagulation.
RESULTS: A total of 9,880 abstracts were screened, with 536 full texts examined to yield a final inclusion of 23 studies that included a total of 8,452 post-cystectomy patients (5,509 no post-discharge anticoagulation, 2,943 with post-discharge anticoagulation). This comprised 12 studies with no post-discharge prophylaxis, 10 studies with post-discharge low molecular weight heparin, and 1 study comparing the two strategies. The rate of DVT was 2.8% in the no anticoagulation group, compared to 1.9% in the anticoagulation group (p[0.013). The rate of PE was 1.25% in the no anticoagulation group compared to 1.29% in the anticoagulation group (p[0.96). Limiting only to studies with 28 days of post-discharge prophylaxis yields a summary rate of 1.9% for DVT, 1.1% for PE.
CONCLUSIONS: Prolonged prophylactic anticoagulation in the published literature likely prevents VTE. The apparent benefit from postdischarge prophylaxis in published studies is much more modest than data used for guideline statements which are based on smaller studies prone to statistical fragility and theoretical extrapolated benefits. In cost effectiveness analyses of post-discharge prophylaxis after cystectomy, conservative sensitivity analyses should be employed when estimating benefits of prophylaxis.
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MP05-11 RECOVERY OF PATIENT-REPORTED FUNCTION, BODY IMAGE AND GENERAL HEALTH AFTER CYSTECTOMY AND URINARY DIVERSION
Charles Peyton*, Richard Reich, Tampa, FL; Carl Henriksen, Gainsville, FL; Mounsif Azizi, Wade Sexton, Michael Poch, Philippe Spiess, Tampa, FL; Paul Crispen, Gainsville, FL; Scott Gilbert, Tampa, FL INTRODUCTION AND OBJECTIVES: Though a morbid surgery, patient-reported deficits and recovery of quality of life (QOL) after cystectomy have not been fully characterized. Prior QOL research after cystectomy is limited by cross-sectional assessment often based on non-specific measures.
METHODS: 150 cystectomy patients were accrued to a prospective QOL study from 2014 to 2016 and followed for 1 year after surgery. Study patients completed a series of questionnaires, including the Bladder Cancer Index (BCI), Body Image Scale (BIS) and Medical Outcomes Study Short Form (SF-36) prior to cystectomy and at 3, 6 and 12 months after surgery. Latent growth modeling was used to examine initial differences after cystectomy (conditional intercepts) and changes in score over time (conditional slopes) according to type of urinary diversion and adjusted for pre-surgery differences, age, sex and comorbidity.
RESULTS: Neobladder (NB) patients experienced significant initial deficits in BCI urinary function scores compared to ileal conduit (IC, p<0.001). Urinary BCI scores remained lower for NB patients from 3-12 months, but scores recovered at a similar rate to those of IC patients. No significant differences were seen for bowel or sexual domains (p>0.05) after cystectomy. Deficits in bowel function were temporary for most patients. Deficits in and partial recovery of sexual function were more pronounced for NB patients. BIS scores were significantly higher (worse body image) for IC patients compared to NB patients (intercept p[0.005) (Figure) . IC patients had lower SF-36 general and mental health scores after cystectomy (6.2 and 4.1 points lower, respectively, p<0.05). SF-36 physical health scores slopes worsened by 1.6 points over time for both IC vs NB patients (p[0.03).
CONCLUSIONS: Both NB and IC are associated with notable deficits in function, body image and general health. For example, urinary function was significantly worse and body image was better for NB patients compared to IC patients. General health and quality of life scores were negatively affected after surgery regardless of diversion type. These data better characterize important functional, body image and general health deficits experiences by patients after cystectomy.
